Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Maria Blanca-Pedregosa"'
Autor:
Jose Luis Fernández-Rueda, Manuel D. Gahete, Jose Valero-Rosa, Julia Carrasco-Valiente, Ana Maria Blanca-Pedregosa, Antonio J. León-González, Vicente Herrero-Aguayo, Jose Lopez-Miranda, Teresa González-Serrano, Juan M. Jiménez-Vacas, M.J. Requena-Tapia, Raúl M. Luque, Enrique Gómez-Gómez, Justo P. Castaño
Publikováno v:
Journal of Cellular and Molecular Medicine
Early detection of PCa faces severe limitations as PSA displays poor‐specificity/sensitivity. As we recently demonstrated that plasma ghrelin O‐acyltransferase (GOAT)‐enzyme is significantly elevated in PCa‐patients compared with healthy‐co
Autor:
Ana Maria Blanca-Pedregosa, M.J. Requena-Tapia, Jose Valero-Rosa, Julia Carrasco-Valiente, Jose Luis Fernandez-Rueda, Pilar Font-Ugalde, Beatriz Barco-Sánchez, Enrique Gómez-Gómez, Helena Molina-Abril
Publikováno v:
Urology. 102:85-91
Objective To externally validate the European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator (RC) and to evaluate its variability between 2 consecutive prostate-specific antigen (PSA) values. Materials and Methods We prospe
Autor:
Juan M. Jiménez-Vacas, Jose Valero-Rosa, Julia Carrasco-Valiente, Ana Maria Blanca-Pedregosa, Enrique Gómez-Gómez, Jesus Ruiz-Garcia, M.J. Requena-Tapia, Juan Pablo Campos-Hernández, Raúl M. Luque
Publikováno v:
Journal of Cellular and Molecular Medicine
Recently, the influence that metabolic syndrome (MetS), hormonal alterations and inflammation might have on prostate cancer (PCa) risk has been a subject of controversial debate. Herein, we aimed to investigate the association between MetS‐componen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca5b4fefc73223c1ea39ee0b7f88c2e1
https://hdl.handle.net/10668/13207
https://hdl.handle.net/10668/13207